Boehringer Ingelheim International GmbH - Company Profile
Powered by 
All the sales intelligence you need on Boehringer Ingelheim International GmbH in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Boehringer Ingelheim International GmbH fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Boehringer Ingelheim International GmbH.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Boehringer Ingelheim International GmbH’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Boehringer Ingelheim International GmbH's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Shashank Deshpande
Chairman; Human Pharma Business Unit Executive BoardMr. Shashank Deshpande has been the Chief Executive Officer and Head of Human Pharma Business Unit of the company since July 2025. Prior to this, he served as the Senior Director, Portfolio Strategy & Alliances at Sanofi-aventis.
Michael Schmelmer
Group Functions; Vice Chairman Executive BoardArmin Wiesler
Animal Health Business Unit; Director Executive BoardPaola Casarosa
Innovation Unit; Director Executive BoardFrank Hubler
Director; Corporate Finance, Accounting, Controlling & Tax Executive BoardStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer